Acasti Pharma reported $66.58M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Acasti Pharma USD 66.58M 3.22M Sep/2025
Addus HomeCare USD 1.44B 14.37M Dec/2025
Amarin USD 659.81M 10.31M Sep/2025
Cassava Sciences USD 129.73M 5.65M Sep/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Option Care Health USD 3.48B 97.02M Sep/2025
Organigram Holdings CAD 562.21M 2.4M Sep/2025
Tilray USD 2.07B 1.33B Mar/2025